Gender as a risk factor for adverse events to medications.
about
Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringEvaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort.Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.Oral contraception does not alter single dose saquinavir pharmacokinetics in womenPattern of Angiotensin-converting enzyme inhibitors induced adverse drug reactions in South Indian teaching hospitalDrug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014.Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.Gender-based personalized pharmacotherapy: a systematic review.Gender: a possible determinant in dosing of dermatologic drugs--an overview.Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.Gender differences in highway driving performance after administration of sleep medication: a review of the literature.Gender differences in drug bioequivalence: time to rethink practices.Sex and gender influences on pharmacological response: an overview.Gender differences in the effects of cardiovascular drugs.Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy.Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.Gender differences in adverse drug reactions.Effect of diltiazem on intraarterial blood pressure and heart rate during stress testing in patients with angina: a gender comparison study.Heart failure and adverse drug reactions among hospitalized older adults.Pharmacological Treatment for Long-Term Patients with Schizophrenia and Its Effects on Sleep in Daily Clinical Practice: A Pilot Study.
P2860
Q27027293-D0AEEE8A-F571-49C7-9805-DCB0E4BC7A67Q34020658-B22CAA72-705F-4453-AF7E-FB9B520A28FAQ35590828-849BA8D7-D477-42C6-9103-53C44F666D93Q35825971-400695BC-B517-4C0E-A6DC-C6E98539A1B7Q35906518-4AE7AE41-4E19-442B-A27B-200E11A19459Q36070432-DF277101-A7A1-4636-966A-011DCB4911D1Q36218118-C733249B-6465-4C21-AF18-AF777A0FECE7Q36335289-AA602D14-E48C-4E9B-9047-33631FB8A61BQ36596188-BBEBD146-37CA-4EF0-8FC8-B57D64EC13D8Q37671280-45101669-4D64-4324-8FEA-34035C5C9673Q38011236-6E4702E0-D587-4EFF-843A-229483C8AAA9Q38072619-FB7FCAA0-E17C-41A7-B218-F8D30B72DF1AQ38214338-45B8C490-F5F3-4051-A343-F96370CE8CD7Q39193538-7AB756E3-92C3-4895-885D-6AE1676518A1Q41971706-078EF980-E1F1-4BA5-9507-1978C7A27461Q43143679-D4FD6E5E-D12A-452C-B7CC-5D70D6C56501Q50856409-688F683F-52B6-4154-97D0-AEB3E31218ACQ50960417-22391D61-D58D-4F1F-BBAE-EB3CABAE0962Q51632780-2476F09E-242D-4CF4-BF52-BD1312DB013CQ55424943-4DD541D2-319B-440E-B0B9-4D7E0C133C30
P2860
Gender as a risk factor for adverse events to medications.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Gender as a risk factor for adverse events to medications.
@en
type
label
Gender as a risk factor for adverse events to medications.
@en
prefLabel
Gender as a risk factor for adverse events to medications.
@en
P2093
P1433
P1476
Gender as a risk factor for adverse events to medications.
@en
P2093
P356
10.2165/00003495-199550010-00001
P577
1995-07-01T00:00:00Z
P6179
1021360551